000 01423 a2200421 4500
005 20250515153850.0
264 0 _c20090206
008 200902s 0 0 eng d
022 _a1875-9572
024 7 _a10.1016/S1875-9572(09)60002-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLin, Hsiang-Yu
245 0 0 _aIntravenous pamidronate therapy in Taiwanese patients with osteogenesis imperfecta.
_h[electronic resource]
260 _bPediatrics and neonatology
_cOct 2008
300 _a161-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aBone Density
_xdrug effects
650 0 4 _aBone Density Conservation Agents
_xadministration & dosage
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aDiphosphonates
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfusions, Intravenous
650 0 4 _aMale
650 0 4 _aOsteogenesis Imperfecta
_xdrug therapy
650 0 4 _aPamidronate
650 0 4 _aRetrospective Studies
650 0 4 _aTaiwan
700 1 _aLin, Shuan-Pei
700 1 _aChuang, Chih-Kuang
700 1 _aChen, Ming-Ren
700 1 _aChang, Chia-Ying
773 0 _tPediatrics and neonatology
_gvol. 49
_gno. 5
_gp. 161-5
856 4 0 _uhttps://doi.org/10.1016/S1875-9572(09)60002-4
_zAvailable from publisher's website
999 _c18582431
_d18582431